Biotech | August 24, 2021
Pfizer to acquire Trillium Therapeutics
Trillium’s portfolio includes biologics that are designed to enhance the ability of patients’ innate immune system to detect and destroy cancer cells
Trillium’s portfolio includes biologics that are designed to enhance the ability of patients’ innate immune system to detect and destroy cancer cells
The group, known as the HIV Obstruction by Programmed Epigenetics (HOPE) Collaboratory, will be led by researchers at Gladstone Institutes, Scripps Research Florida, and Weill Cornell Medicine. Their approach, which aims to both silence and permanently remove HIV from the body, takes advantage of knowledge about how other viruses have become naturally inactivated over time.
Lenalidomide is used to treat cancer and also some anaemia disorders
This therapy may provide the first potential oral treatment for COVID-19, recognizing the global emergency of new SARS-CoV-2 variants
The company has strong product launches both in India and overseas
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
It had an estimated market size of US $ 32 million as of June 2021
Subscribe To Our Newsletter & Stay Updated
